Xylem Inc. (NYSE:XYL) Receives “Outperform” Rating from Cowen and Company

Cowen and Company reaffirmed their outperform rating on shares of Xylem Inc. (NYSE:XYL) in a research note issued to investors on Wednesday morning. Cowen and Company currently has a $70.00 price objective on the industrial products company’s stock, up from their prior price objective of $60.00.

XYL has been the subject of several other reports. BMO Capital Markets started coverage on Xylem in a research note on Wednesday, June 21st. They issued an outperform rating and a $60.00 price objective for the company. Canaccord Genuity restated a hold rating and issued a $50.00 price objective on shares of Xylem in a research note on Friday, July 28th. BidaskClub upgraded Xylem from a hold rating to a buy rating in a research note on Wednesday, June 28th. Oppenheimer Holdings, Inc. set a $58.00 price objective on Xylem and gave the stock a buy rating in a research note on Tuesday, June 20th. Finally, Barclays PLC upgraded Xylem from an equal weight rating to an overweight rating and upped their price objective for the stock from $51.00 to $59.00 in a research note on Monday, May 15th. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company currently has a consensus rating of Buy and an average price target of $59.00.

Xylem (NYSE:XYL) traded down 1.22% during mid-day trading on Wednesday, reaching $58.98. The company’s stock had a trading volume of 598,279 shares. Xylem has a 12-month low of $45.60 and a 12-month high of $60.71. The firm has a market cap of $10.59 billion, a PE ratio of 38.08 and a beta of 1.18. The company has a 50-day moving average price of $56.50 and a 200-day moving average price of $51.83.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, August 1st. The industrial products company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.57 by $0.02. The firm had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.17 billion. Xylem had a return on equity of 16.02% and a net margin of 7.08%. Xylem’s revenue was up 24.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.48 EPS. On average, equities research analysts expect that Xylem will post $2.37 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This report was published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://stocknewstimes.com/2017/08/10/xylem-inc-nysexyl-receives-outperform-rating-from-cowen-and-company.html.

In related news, Director Steven R. Loranger sold 66,132 shares of the company’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the transaction, the director now owns 65,030 shares of the company’s stock, valued at approximately $3,577,300.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Kenneth Napolitano sold 9,052 shares of the company’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $60.16, for a total transaction of $544,568.32. Following the completion of the transaction, the insider now directly owns 35,303 shares of the company’s stock, valued at approximately $2,123,828.48. The disclosure for this sale can be found here. Corporate insiders own 0.75% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. increased its position in shares of Xylem by 2,452.8% in the first quarter. BlackRock Inc. now owns 12,042,342 shares of the industrial products company’s stock valued at $604,765,000 after buying an additional 11,570,613 shares in the last quarter. USS Investment Management Ltd purchased a new position in shares of Xylem during the second quarter valued at $91,840,000. MARSHALL WACE ASIA Ltd bought a new position in Xylem during the first quarter valued at approximately $54,623,000. Marshall Wace North America L.P. bought a new position in Xylem during the first quarter valued at approximately $54,623,000. Finally, Pictet Asset Management Ltd. increased its position in Xylem by 34.3% in the first quarter. Pictet Asset Management Ltd. now owns 4,024,188 shares of the industrial products company’s stock valued at $202,095,000 after buying an additional 1,027,438 shares during the period. 86.41% of the stock is owned by institutional investors.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply